Plus Therapeutics Inc. (PSTV)
NASDAQ: PSTV
· Real-Time Price · USD
0.67
-0.01 (-2.00%)
At close: Oct 01, 2025, 1:48 PM
-2.00% (1D)
| Bid | 0.48 |
| Market Cap | 40.23M |
| Revenue (ttm) | 5.32M |
| Net Income (ttm) | -19.03M |
| EPS (ttm) | -1.87 |
| PE Ratio (ttm) | -0.36 |
| Forward PE | -7.56 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 0.77 |
| Volume | 23,206,905 |
| Avg. Volume (20D) | 22,213,714 |
| Open | 0.59 |
| Previous Close | 0.68 |
| Day's Range | 0.59 - 0.69 |
| 52-Week Range | 0.16 - 2.31 |
| Beta | 0.66 |
| Ex-Dividend Date | n/a |
About PSTV
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol PSTV
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for PSTV stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsPlus Therapeutics Inc. is scheduled to release its earnings on
Nov 13, 2025,
after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
6 days ago
+39.29%
Plus Therapeutics shares are trading higher after ...
Unlock content with
Pro Subscription
1 month ago
-14.62%
Plus Therapeutics shares are trading lower after Maxim Group cut its price target on the stock from $4 to $3.
